Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-073568

Chairman & CEO bought 500 shares at $17.88 ($8,940)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-21 Purchase : show line 1 in the form +500 $17.88 $8,940 3,230,029 D
Open-market purchases · 500 sh · avg $17.88 · $8,940
Loading xslF345X04/tm2319376-1_4seq1.xml…